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Summary
Background: The diagnosis of pulmonary tuberculosis (PTB) is conventionally established by
examination of three Ziehl—Neelsen stained smears; however, negative results do not preclude
active TB. Since tubercle bacilli or their nucleic acids are also expected to be excreted through the
kidneys, we assessed spot urine as a supplementary specimen for diagnosing PTB.
Methods: A total of 164 respiratory specimens (147 sputum, 15 bronchoalveolar lavage, and two
gastric lavage) from 81 suspected PTB cases were prospectively collected and processed. A total of
112 non-TB controls were also included in the study. For three consecutive days, morning urine
specimens were collected from all patients and controls, and were processed for culture by
BACTECTM MGIT 960 (mycobacteria growth indicator tube) and Lowenstein—Jensen methods and
for PCR by amplifying a 441-bp fragment of the hsp65 gene (Mycobacterium genus-specific) and a
786-bp fragment of the cfp32 gene (TB complex-specific).
Results: Of the 81 patients suspected of having PTB, 46 (56.8%) were sputum culture-positive. Of
these, 12 (26.1%) were also urine culture-positive for Mycobacterium tuberculosis. Of the 35
sputum culture-negative cases, three (8.6%) were urine culture-positive. The TB complex specific
PCR (cfp32) was positive in 52.2% (24/46) of the bacteriologically-confirmed and 28.6% (10/35) of
the bacteriologically-negative PTB patients. In none of the control subjects were urine culture or
PCR found to be positive for M. tuberculosis.
Conclusions: Specific PCR and culture examination of spot urine samples from suspected PTB
patients significantly improved the detection rate of PTB and should be encouraged in resource-
limited settings and where multiple pulmonary specimens are not feasible.
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Tuberculosis (TB) is a major public health problem of global
importance and it is the second leading cause of death
worldwide, killing nearly 1.6 million people in 2005.1 SeveralPublished by Elsevier Ltd. All rights reserved.
Utility of urine in the diagnosis of PTB 375studies have identified the clinical manifestations and symp-
tomatology of sputum smear-positive individuals.2—4 The
most common method for the diagnosis of pulmonary tuber-
culosis (PTB) is microscopic examination of Ziehl—Neelsen
stained smears, which has a variable detection rate of 20—
70%.5 However, approximately 20—50% of patients with PTB
are smear-negative, and 10% of these patients remain
culture-negative, even on three consecutive days.5 This
phenomenon is more common in patients infectedwithmulti-
drug-resistant Mycobacterium tuberculosis (MDR-TB).6 Sev-
eral studies have also shown that most of the smear- and
culture-negative patients will develop bacteriologically-
positive disease in the course of time.2,5,7 In sputum-scarce
PTB cases, bronchoalveolar lavage (BAL) fluid is a preferred
clinical specimen in adults and gastric lavage in young chil-
dren, but these specimens can be obtained only in a tertiary
healthcare setting and have very low detection rates.5,8
Colby postulated that tubercle bacilli could be excreted
through the kidneys and that the organisms could be
demonstrated in the urine of active TB patients who have
no symptoms pertaining to the urinary tract.9 This hypoth-
esis was confirmed by studies carried out in HIV-negative10—
12 and HIV-positive cases.13,14 These studies showed that
urine could be used as an adjunct specimen due to the
convenience and non-invasive nature of collection. How-
ever, in smear- and culture-positive cases it may not be
necessary to include other samples, and such studies may
be a matter for the records only. A study by Torrea et al.15
confirmed the utility of urine specimens for diagnosing PTB
by nested PCR with a sensitivity of 64.3% in culture-negative
PTB cases and 46.3% in extra-pulmonary tuberculosis (EPTB)
cases. Though India harbors the majority of TB cases, no
such study has yet been undertaken in this country. There-
fore we carried out this study in order to evaluate the utility
of urine as an adjunct or alternative specimen for diagnos-
ing smear- and/or culture-negative PTB, using culture and
PCR methods.
Materials and methods
Patients and specimens
This prospective hospital-based study was conducted from
July 2005 to June 2006 at the Department of Laboratory
Medicine, All India Institute of Medical Sciences (AIIMS), New
Delhi, India. AIIMS is a tertiary care medical center. During
the study period, the clinical data of 215 patients with
suspected PTB, referred from various clinics of this institute
and other hospitals in and around Delhi for mycobacterial
culture, were investigated. Only 81 of these fulfilled the
inclusion criteria and were recruited into this study.16,17 A
total of 112 healthy volunteers, including 15 laboratory
staff,with no present or past history of TBwere also included
in the study as control subjects. Cases of suspected genito-
urinary TB with symptoms of burning micturition, unex-
plained sterile pyuria, or hematuria, and/or cases ultraso-
nographically suggestive of pyelonephritis were excluded
from the study. Also only anti-tuberculosis treatment (ATT)-
naı¨ve patients were included in the study. The results of
routine laboratory investigations such as erythrocyte sedi-
mentation rate (ESR), total leukocyte count, and liverenzyme values were recorded for both the suspected TB
and control subjects.
To establish the presence of PTB, at least two sputa (spot
and early morning) were collected from each patient with a
productive cough. BAL or gastric lavage specimens were
taken from sputum-scarce patients. The sputum specimens
were collected and brought to the laboratory by the patients
themselves. The sputa received from the suspected PTB
patients were first decontaminated by NALC-NaOH (modified
Petroff’s method) as previously described.18
An early morning or spot urine sample (approximately
500 ml) was also collected simultaneously from the patients
and controls in a sterile wide-mouthed container for three
consecutive days; the first two samples were stored in a
refrigerator and all three samples were then pooled and
processed on the third day. The pooled urine specimens from
each patient were centrifuged at 3000  g for 20 min. The
resulting pellet was decontaminated with an equal amount of
4% NaOH. After incubation for 15 minutes, the suspension
was neutralized with phosphate-buffered saline (PBS; pH 6.8)
and again centrifuged at 10 000 rpm for 20 min.
The pellets of decontaminated respiratory and urine spe-
cimens were resuspended in PBS; smears were made for
Ziehl—Neelsen staining and 0.1 ml was inoculated on Low-
enstein—Jensen (L—J) slants while 0.5 ml was inoculated in
BACTECTM MGIT 960 tubes (mycobacteria growth indicator
tube; BD Diagnostics, Sparks, MD, USA) for culture isolation.
The remaining aliquots of the suspended pellets were stored
at 80 8C and processed further for DNA isolation and ana-
lysis by PCR. Sputum and urine samples were processed
separately to avoid possible cross-contamination.
The L—J slants were incubated at 37 8C for 6 weeks.18 The
inoculated MGIT 960 tubes were loaded into the BACTECTM
MGIT 960 system, and the growth was continuously monitored
in fluorescence units, which flash positive after reaching a
cut-off growth set by the manufacturer. Ziehl—Neelsen stain-
ing for acid-fast bacilli (AFB) was used to confirm positive
BACTECTM MGIT 960 tubes and any growth on L—J medium;
Gram staining was also carried out to check for contamina-
tion. The specimens having AFB with contaminants were
reprocessed as per the protocol above, while the others were
discarded. Cultures were considered negative for mycobac-
terial culture only after 42 days, as per the manufacturer’s
guidelines. The Mycobacterium species isolated from the
clinical specimens were identified by phenotypic and bio-
chemical tests, including heat stable catalase, nitrate, nia-
cin, and arylsulfatase tests.18
DNA isolation and analysis by PCR
The DNA from an aliquot of the decontaminated specimens
was isolated as described previously by Ausubel et al.19 In
brief, the decontaminated pellets were lysed with lysozyme
and proteinase K—SDS, and DNA extracted by the phenol
chloroform method followed by precipitation with 70% ice-
cold ethanol. The resulting DNA pellets were solubilized in
Tris—EDTA buffer and used for the PCR. Mycobacterium
genus-specific PCR was done by amplifying a 441-bp fragment
of the hsp65 gene20 and TB complex-specific PCR by amplify-
ing a 786-bp fragment of the cfp32 gene.21 The PCR master
mix was prepared by combining 500 mM KCl, 100 mM Tris HCl
376 K. Gopinath, S. Singh(pH 9.0), 0.2 mM each deoxynucleoside triphosphate (dATP,
dGTP, dTTP, and dCTP), 1.5 mM MgCl2, 20 mM cfp32 forward:
50-ACCAACGATGGTGTGTCCAT-30 and cfp32 reverse: 50-
CTTGTCGAACCGCATACCCT-30 primers and 1 U of Taq DNA
polymerase (Promega, USA). To 20 ml of this master mix,
5 ml of template DNAwas added. The reaction was carried out
in an MTC-100 thermal cycler (MJ Research, USA). The genus-
and TB complex-specific PCRs were run separately with a
program of an initial denaturation at 96 8C for 10 min, fol-
lowed by cycles of denaturation at 94 8C for 1 min, annealing
at 60 8C for 1 min, and extension at 72 8C for 1 min, and a final
extension at 72 8C for 10 min. The TB complex- and genus-
specific PCRs were programmed with 30 and 45 cycles,
respectively. DNA isolated from the standard strains of M.
tuberculosis H37 Rv andMycobacterium avium (kind gift from
Dr V.M. Katoch, NJILOMD, Agra, India) were included as
positive controls and sterile water as negative control, in
each run; all precautions to prevent cross-contamination
were taken. Amplified products were electrophoresed
through a 2% agarose gel in Tris—acetate buffer. Target bands
of 441 bp for the genus-specific PCR and 786 bp for the M.
tuberculosis complex-specific PCR were visualized by stain-
ing with ethidium bromide. The samples found negative by
genus- and TB-specific PCR were ruled out of PCR inhibition
by amplifying the human g-globulin gene with a product of
578 bp as an internal control.22
Results
Clinical details
The clinical data of 215 suspected cases of TB were avail-
able for analysis during this period, but only 81 cases could
be included in the study after applying the inclusion criteria
as described in the Materials and methods. Of the 81 cases,
58 (71.6%) were male and 23 (28.4%) female, with a mean
age of 48  12.4 years. The most common symptoms
observed in these patients were fever in 77 (95.1%), weight
loss in 71 (87.7%), cough with expectoration in 64 (79.0%)
and without expectoration in 10 (12.3%), raised ESR in 58
(71.6%), and hemoptysis in 10 (12.3%). Four (4.9%) patients
had no fever but presented with cough and weight loss. All
patients were ATT-naı¨ve, but in 16 (19.8%) cases there was
history of empiric fluoroquinolone treatment prescribed by
the local physicians before the patient was referred to our
hospital.Table 1 Total number of respiratory samples collected and thei
Nature of sample Number of cases Mycobacterial dete
Microscopy-
positive
L—
po
Sputum (n = 147) 64 42 (28.6%) 62
BAL (n = 15) 15 0 0
Gastric lavage (n = 2) 2 0 0
Total (n = 164) 81 42 (25.6%) 62
L—J, Lowenstein—Jensen; MGIT, mycobacteria growth indicator tube; P
BAL, bronchoalveolar lavage.Pulmonary samples
Of the 81 patients, 64 had a productive cough and provided
sputum samples (n = 147 samples). For the remaining 17
patients, BAL (n = 15) and gastric lavage (n = 2) samples were
obtained. Therefore, a total of 164 samples were processed
for mycobacterial smear, culture, and PCR tests. With the
exception of sputum, samples were only taken once from
each patient. Overall 46 of the 81 (56.8%) suspected PTB
patients were confirmed to be positive by culture, either by
sputum (n = 43) or BAL (n = 3) examination, while 35
remained smear- and culture-negative.
Smear, culture, and PCR findings
Of the 64 patients who provided sputa (n = 147), PTB could be
confirmed bacteriologically (either by smear and/or culture)
in 43 patients (n = 98 sputa), while for 21 patients (49 sputum
samples) PTB could not be confirmed by either of these
methods. From the 43 bacteriologically-confirmed PTB
patients, we obtained 98 sputum samples, and 42 (42.9%) of
these sputa obtained from 21 (48.8%) patients were both
smear- and culture-positive. The remaining 56 (57.1%) sputa
from 22 (51.2%) patients were smear-negative but culture-
positive. Of the 15 BAL samples none were smear-positive and
only three were culture-positive, while 12 remained negative
by both methods. No gastric lavage sample was detected
positive by smear or culture examination (Table 1). Between
the two culture systems, the mycobacterial isolation rate of
BACTECTM MGIT 960 was statistically significantly higher than
that of the L—J culture method (Chi-square test, p = 0.01). As
expected, the mycobacterial detection rate of the PCR sys-
tems was comparatively higher than that of any of the culture
methods (Chi-square test, p = 0.001).
Urine specimens
Urine samples from 81 suspected PTB patients were sub-
jected to smear, culture, and PCR examinations. Of these, 15
(18.5%) were culture-positive by BACTECTM MGIT 960. How-
ever, the culture isolation rate was significantly higher
(38.1%) if the pulmonary samples from the same patient
were also smear- and culture-positive as compared to those
patients whose pulmonary samples were smear-, culture-,
and PCR-negative (5.6%) (Table 2). This difference was highly
significant ( p < 0.001). It is also important to note thatr positivity rate by different tests carried out in the study.
ction rate from the respiratory specimens
J-
sitive
MGIT-
positive
Genus-specific
PCR-positive
MTB complex-
specific PCR-
positive
(42.2%) 98 (66.7%) 121 (82.3%) 117 (79.6%)
3 (20%) 6 (40%) 6 (40%)
0 1 1
(37.8%) 101 (61.6%) 128 (78.0%) 124 (75.6%)
CR, polymerase chain reaction; MTB, Mycobacterium tuberculosis;
Table 2 Mycobacteriuria detection rate of various in vitro diagnostic methods applied to urinary specimens from pulmonary
tuberculosis patients.
Suspected PTB cases (N = 81) (and results
of pulmonary samples)
Detection rate of mycobacteriuria
Microscopy L—J MGIT Genus-specific
PCR
MTB-specific
PCR
Bacteriologically-confirmed PTB (N = 46)a 3 (6.5%) 5 (10.9%) 12 (26.1%) 25 (54.3%) 24 (52.2%)
Smear-, culture-, and PCR-positive (N = 21) 3 (14.3%) 4 (19.0%) 8 (38.1%) 13 (61.9%) 13 (61.9%)
Smear-negative, culture- and PCR-positive (N = 25) 0 1 (4%) 4 (16%) 12 (48%) 11 (44%)
Bacteriologically-negative PTB (N = 35)b 0 0 3 (8.6%) 11 (31.4%) 10 (28.6%)
Smear- and culture-negative and PCR-positive (N = 17) 0 0 2 (11.8%) 7 (41.2%) 7 (41.2%)
Smear-, culture-, and PCR-negative (N = 18) 0 0 1 (5.6%) 4 (22.2%) 3 (16.7%)
Controls (N = 112) 0 0 1c 2c 0
PTB, pulmonary tuberculosis; L—J, Lowenstein—Jensen; MGIT, mycobacteria growth indicator tube; PCR, polymerase chain reaction; MTB,
Mycobacterium tuberculosis.
a At least one specimen from a patient was positive in smear and/or L—J or BACTEC MGIT 960 culture and/or PCR.
b Specimen(s) collected from a patient were either positive or negative by PCR and negative by both smear and culture.
c Non-tuberculous mycobacteria detected.
Utility of urine in the diagnosis of PTB 377approximately 12% of patients whose other investigations on
pulmonary specimens were all negative could also be found
urine culture-positive by MGIT 960. Of the 15 BAL samples,
three were culture-positive, as mentioned above, but the
urine culture from only one patient (33.3%) was positive.
Nevertheless, urine cultures from two patients (13.3%) were
MGIT 960 culture-positive. No urine sample from a sputum-
scarce patient was smear- or L—J culture-positive. There-
fore, the cumulative total of bacteriologically-confirmed
cases among the sputum-scarce TB cases increased from
17.6% (3/17) to 29.4% (5/17) by using urine as an adjunct
specimen.
With the application of genus-specific PCR, overall 25 of 46
(54.3%) bacteriologically-confirmed PTB patients were found
PCR-positive suggesting mycobacteriuria. The PCR positivity
could reach as high as 61.9% in sputum smear-positive cases.
Even in those patients whose pulmonary samples were nega-
tive by all bacteriological methods, the urine PCRwas positive
in 31.4% of patients. Therefore, the application of PCR for
urine samples was most rewarding in both bacteriologically-
confirmed and -unconfirmed patients (Table 2).
Irrespective of the PCR results, all the cases were treated
with ATT as per the RNTCP (Revised National Tuberculosis
Control Programme), India guidelines. Of the 24 bacteriolo-
gically-confirmed cases using both respiratory and urine
specimens, only six (25%) could be followed up and four
responded to ATT. Among the 22 bacteriologically-confirmed
but urine culture- and PCR-negative PTB cases, 13 (59.1%)
could be followed up and nine (40.9%) of them responded to
the treatment. Of the 11 urine PCR-positive but bacteriolo-
gically-negative PTB cases, all were followed up and nine
(81.8%) of them responded to the treatment. Of the eight
patients sputum PCR-positive but negative by all other tests,
four were followed up and two responded to ATT. In those who
responded to ATT, their fever and cough disappeared, they
gained weight, and repeat respective samples after 3 months
became negative by both culture and PCR methods.
Discussion
The African region, China, and India collectively account for
69% of undetected TB cases.1 Unfortunately, for the last fewyears the progress of PTB case detection has decelerated
globally; it has almost stalled in India and China and fell short
of the global planned milestone of 65%.1 The paucibacillary
form of TB is a major diagnostic challenge. This is the most
challenging task in TB endemic and resource-poor countries
where infrastructure, the cost of equipment and reagents,
and the lack of suitably trained staff are the major concerns.
Therefore, rapid diagnostic methods like PCR could be the
future hope. However, obtaining good quality sputum speci-
mens or other pulmonary samples is always problematic. In
the present study we attempted to apply the most sensitive
diagnostic tool to the most easily available clinical sample,
i.e., urine, with an improved detection rate. In our study,
when urine samples were tested along with pulmonary speci-
mens and when genus- and species-specific and sensitive PCR
methods were applied to these samples, we were able to
detect an additional 41.2% of PTB cases. These findings are
highly significant and encouraging for at least tertiary health-
care level settings. Not only PCR but urine culture methods
also improved the mycobacterial isolation rate.
Nevertheless, the bacteriological confirmation of TB from
the appropriate clinical specimen cannot be undermined. It is
of significance not only for effective management but also for
speciation of the isolate, its characterization, and anti-
mycobacterial drug susceptibility studies. Paucibacillary TB
poses a challenge in establishing the correct diagnosis and
management and in the containment of spread of drug-
resistant PTB.6,23 In sputum-scarce or sputum smear- and
culture-negative cases, the usual alternative specimens are
BAL and gastric lavage fluids, but collection of these speci-
mens is often painful and awkward, and these specimens add
insignificant advantage. Our study also shows a very limited
improvement in detection rate.
There are only a few studies demonstrating the utility of
urine as a clinical specimen in diagnosing TB in both HIV-
positive and HIV-negative cases. Torrea et al.15 evaluated the
utility of urine specimens using a nested PCR assay in sus-
pected TB cases. However, the major limitation of their
study was a lack of bacteriological confirmation of the urine
specimens and true positivity rate of PCR. In addition, no
analysis was made to correlate the positive predictive value
of urine with the other site-specific specimens analyzed in
378 K. Gopinath, S. Singhtheir study. Another recent study by Rebollo et al. in 2006,24
dealt with this limitation and correlated the results of their
PCR with bacteriologically-confirmed urine specimens. But in
this study, only 14 smear-negative PTB cases were included.
Therefore, the false positivity of PCR and cost-effectiveness
of using urine as an adjunct specimen could not be evaluated
in a group of smear- and culture-negative TB patients.
In the present study, an attempt was made to evaluate the
feasibility of using urine as an adjunct specimen in diagnosing
mycobacterial infection. The results show that more than a
quarter (26.1%) of the smear- and/or culture-positive PTB
cases also excreted M. tuberculosis in their urine specimens.
Excretion of M. tuberculosis was reported as early as in 1975
by Bentz et al.10 Two recent studies also reproduced the
findings of Bentz et al. using modern diagnostic tools.15,24
However, no previous study has reported so high a culture
isolation rate ofM. tuberculosis from urine as reported in the
present study. This could be because the earlier authors15,24
centrifuged urine samples at 3000  g with an isolation rate
of only 19%, while we in the present study used 10 000 rpm for
processing the urine samples, and we feel strongly that in
future studies clinical pathologists should use 10 000 rpm
speed for urine samples. Centrifugation plays a very impor-
tant role in the retrieval of living mycobacteria. A higher
detection rate was also found while culturing respiratory6
and other non-respiratory specimens if a higher centrifuga-
tion speed was used (data not shown).25
In comparison with the smear and culture methods, PCR
was more sensitive in our study, and in addition, PCR was
positive in 31.4% of bacteriologically-negative samples using
genus-specific primers and 28.6% using M. tuberculosis-com-
plex-specific primers. A similar detection rate has been
reported from Burkina Faso,15 Spain,24 and India.26
However, these studies also show that mycobacteriuria is
not a continuous process. This is further evident from our
results of 46 culture-proven PTB cases; even using the most
sensitive culture system only 12 (26.1%) patients had culti-
vable mycobacteriuria. However, PCR detected mycobac-
terial DNA in as many as 54.3% of urine samples, suggesting
that the excretion of DNA is a comparatively more contin-
uous phenomenon. We ruled out positivity of our PCR system
using all possible internal and patient controls (Table 2). In
fact the PCR was not positive in all the urine samples from
mycobacteriologically-confirmed cases, suggesting a high
specificity but optimized sensitivity. The low positivity rate
of PCR in proven PTB cases could be explained by the fact
that not all of the patients with PTB will have circulating
mycobacteria that will be filtered out of the kidneys through
the urine. It is also possible that M. tuberculosis or its
fragments may or may not have been excreted during the
time of sample collection.27—29 Furthermore, the PCR reac-
tion was found inhibited in four samples, which was evident
from the amplification of internal controls. Endogenous PCR
inhibitors like acidic polysaccharides, glycoproteins, urea,
and unidentified non-proteinaceous DNA-associated sub-
stances cause chelation of free magnesium ions and are
known to inhibit the PCR amplification.30
As in most developing and resource-poor countries,
laboratory diagnosis of TB remains a problem because of a
lack of laboratory facilities and increased workload, mostly
due to high HIV seroprevalence. This high rate of undiagnosed
or unconfirmed TB contributes significantly to treatmentdelays and often to the development of drug resistance.
Therefore the development of sensitive and rapid diagnostic
tools is urgently required, and our laboratory is working in
that direction. The results of this study lead us to suggest that
urine specimens along with the other respiratory specimens
will possibly increase the chance of diagnosing active TB,
especially in sputum smear-negative/scarce pulmonary TB
cases. This is more important if we apply PCR on this easily
available clinical material. It may minimize the use of more
invasive techniques for collecting samples, such as BAL and
gastric lavage. We also recommend that when other clinical
specimens have failed to confirm the diagnosis, a urine
sample be used for culture isolation and PCR tests.
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